logo
Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: AIDS
Load new posts () and activity
Like Reblog Comment
text 2019-06-27 10:43
Best HIV Treatment in India | Malaivel Siddha

Let not the deadly disease over rule you!

 

Are you facing any symptoms that are common to HIV? Do not hesitate to have a screening test for HIV. If you are HIV negative, then really we are the first person to feel happy. But if the result turns out positive, do not worry, we provide the Best HIV Treatment in India. With our Best HIV Treatment in India, your CD4 count will be increased and the immune system will be enhanced so that you can easily fight HIV and get rid of it. For more details regarding our Best HIV Treatment in India, you can contact us at any time.

 

The Best HIV Treatment in India follows the natural remedies such that people do not experience any side effects. In order to attain maximum health and stay strong throughout your life, get the Best HIV Treatment in India. Our treatments are also affordable and can be essential at times. To gain more confidence over our treatment, you can check the reports of our patients from our website. Our Best HIV Treatment in India has cured them and reduced the stage of symptoms that they faced previously and now they are living happily as a normal HIV negative person. 

 

 

If you are looking for the Best HIV Treatment in India? Then without any further discussion, you can connect with us. And, our specialist doctors are ready to provide you with the Best HIV Treatment in India. We treat every patient well and grant them with the best care. Our Best HIV Treatment in India will make you healthy and keep you away from the deadly diseases. So if you consider us for your treatments you can contact us at any time. And, we are ready to provide you with the Best HIV Treatment in India, call us now for treatments.

 

 

 

 

Malaivel Siddha Hospital 

Karivalam Vanda Nallur, Sankarankovil (Tk)

 

Tirunelveli - 627 753.

 

Call : 9345998674

 

Tamilnadu, South India

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Source: www.malaivelsiddhahospital.in/hiv-aids-treatment-mumbai.html
Like Reblog Comment
text 2019-05-29 08:41
Sleep aids market to witness widespread expansion by 2025

According to the Mindaspire Market Research (MAMR), titled ‘Global Sleep AidsMarket’: Industry Analysis 2012-2016 and Opportunity Assessment 2017-2025. The global sleep aids market is expected to expand at a CAGR of 4.8% during the forecast period 2017-2025.

 

The global sleep aids market, forecasted to be worth US$ 31,315.4 Mn by 2025 end, and is expected to increase at a CAGR of 4.8% throughout forecast period. In terms of revenue,others product type segment-consisting of mattresses and pillows, chin straps and mouth pieces & nasal devicesis projected to remain dominant. By indication type, insomnia segment is expected to be most dominant segments and collectively gain more the 35% market share over the forecast period.Sleep apnea segment is expected to gain more traction than narcolepsy over the next decade owing to rising prevalence of obstructive sleep apnea.Among all distribution channel e commerce segment is the second most dominant segment for sleep aids market which is then followed by hospital pharmacies. Asia-Pacific is the second most lucrative region for the sleep aids market and projected to grow at fastest CAGR over the forecast period.

 

On the basis of region, the market has been segmented into North America, Latin America, Europe, Asia Pacific, and Middle East and AfricaNorth America is the largest market, and is expected to increase at over 4.3% CAGR during the forecast period. Asia-Pacific is the fastest growing marketplace for sleep aids market and projected to grow with CAGR of 6.5% to reach US$ 6,622 Mn by 2025.

 

Request for a sample of report @

https://mindaspiremarketresearch.com/request-sample/report/sleep-aids-market-global-industry-analysis-size-sales-and-forecast-by-2025

 

The primary factors driving the growth of sleep aids market are increasing prevalence of sleep disorders such assleep apnea, insomnia, narcolepsy, sleep deprivation and others. The healthcare facilities are focusing on the implementation of several educational programme to raise awareness among the general population regarding the ill effects caused due to untreated sleep disorders and this will upsurge the demand for sleep aids drugs and devices products in near future. Other factors influencing growth of global sleep aids market include growing awareness about the sleep related disorders, rise in online sales, and others.

However, lack of awareness in developing countries about the major issues related with sleep disorder is the major factor deteMAMRng the growth of sleep aids market.

Some key players in the global sleep aids market across the value chain areResMed Inc., Koninklijke Philips N.V., Merck & Co. Inc., Drive DeVilbiss Healthcare LLC, GlaxoSmithKline Plc., Fisher & Paykel Healthcare Limited, Sanofi SA, and Pfizer Inc.Leading manufacturer are focusing to expand their regional presence in the emerging geographies such as APAC and MEA by collaborating with the distributers.

 

Ask an Analyst @

https://mindaspiremarketresearch.com/inquire/report/sleep-aids-market-global-industry-analysis-size-sales-and-forecast-by-2025

 

The global Sleep Aids Market is segmented as follows:

 

By Product Type

  • Drugs

     - Insomnia Treatment Drugs

  • Doxepin Hydrochloride
  • Eszopiclone
  • Ramelteon
  • Triazolam
  • Zaleplon
  • Quazepam
  • Others

     - Narcolepsy Treatment Drugs

  • Modafinil
  • Sodium Oxybate
  • Armodafinil
  • Others
  • Devices

     - CPAP Devices

     - BiPAP Devices

     - APAP Devices

  • Others

     - Mattresses and Pillows

     - Chin Straps

     - Mouth Pieces and Nasal Devices

 

By Indication Type

  • Insomnia
  • Sleep Deprivation
  • Narcolepsy
  • Sleep Apnea
  • Others

 

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • e commerce
  • Drug Stores
  • Others

 

By Region

  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Middle East & Africa
Like Reblog Comment
text 2019-05-01 06:13
Buy International Licensed Pharmacies FDA Approved Drugs - CANCER, HIV, COPD DIABETES, HEPATITIS

 

ARSENIC TRIOXID 1 ml Injection vial

BICALUTAMIDE 50 mg, 150 mg tablet

BORTEZOMIB 1 mg, 2 mg and 3.5 mg Injection Vial

Capecitabine 500 mg Tablet

Carboplatin 450 mg Injection Vial

Cisplatin 10 mg Injection vial

Cyclophosphamide 200 mg Injection vial

CYTARABINE 500 mg Injection vial

Dactinomycin 500 mcg Injection vial

Dasatinib 20 mg tablet

Doxorubicin 10 mg Injection vial

Erlotinib 100 mg Tablet

Exemestane 25 mg tablet

Finasteride 5 mg Tablet

Fluorouracil 250 mg Injection vial

Fosfestrol 120 mg tablet

Gefitinib 250 mg tablet

Gemcitabine 200 mg Injection vial

Goserelin 3.6 Syringe

Granisetron 3 mg Injection vial

Hydroxyurea 500 mg capsule

Idarubicin 5 mg capsule

Irinotecan 40 mg Injection vial

Letrozole 2.5 mg tablet

Leucovorin Calcium 15 mg Injection vial

Leuprolide 3.75 mg injection vial

Megestrol Acetate 40 mg tablet

Mercaptopurine 50 mg tablet

Methotrexate 2.5 mg tablet

Ormeloxifene 30 mg tablet

Oxaliplatin 50 mg Injection vial

Pemetrexed 100 mg injection vial

Tamoxifen 10 mg tablet

Temozolomide 20 mg Capsule

Thioguanine 40 mg Tablet

Topotecan 2.5 mg Injection Vial

Triptorelin .1 mg Injection

Eltrombopag Olamine 25 mg Tablet

Lapatinib Ditosylate 250 mg Tablet

Pazopanib 400 mg Tablet

Nilotinib 200 mg capsule

Altretamine 50 mg capsule

Ibandronic Acid 6 mg Injection vial

Ifosfamide 500 mcg Injection vial

Sorafenib 200 mg Tablet

Palonosetron .25 mg Injection vial

Aprepitant 125 mg capsule

Bendamustine 100 mg Injection vial

Busulfan 60 mg Injection

Procarbazine 50 mg capsule

Tretinoin 10 mg capsule

Sunitinib 12.5 mg capsule

Decitabine 50 mg Injection vial

Deferasirox 400 mg Tablet

Abiraterone Acetate 250 mg Tablet

Alendronate Sodium 10 mg tablet

Crizotinib 250 mg Capsule

Cyclosporine 50 mg capsule

Deferoxamine 500 mg Injection vial

Everolimus 10 mg tablet

Ritonavir 50 mg tablet

Mitomycin 2 mg injection vial

Mycophenolate Mofetil 250 mg Tablet

Nevirapine 200 mg Tablet

Ondansetron 4 mg tablet

Ruxolitinib 5 mg tablet

Tenofovir 300 mg tablet

Valganciclovir 450 mg Tablet

Voriconazole 200 mg tablet

Zoledronic Acid 4 mg reconstitution vial

 

Source: www.cancercurepharmacy.com
Like Reblog Comment
text 2019-02-12 08:51
Sleeping Aids Market Trends Research And Projections For 2018-2026

Sleeping aids, also known as hypnotics are sleeping pills or devices, which are used to induce sleep. It is used in the treatment of various sleeping disorders such as narcolepsy, sleep apnea, and insomnia, which are caused due to factors such as psychiatric disorders (Depression and anxiety), environmental problems (light, noise and extreme temperatures) medical issues (asthma) and others. Click To Read More on Sleeping Aids Market


Sleeping aid medications include non-benzodiazepines, antidepressants, and antipsychotics for the treatment of sleeping disorders. However, various behavioral therapies such as light therapy, cognitive behavioral therapy, and relaxation techniques are also used in the treatment of these disorders. According to Centers for Disease Control and Prevention (CDC), in 2017, around 49.2 million people across the globe have trouble focusing due to lack of sleep.


Rising incidences of insomnia is expected to fuel growth of the sleeping aids market


One of the major factors contributing to growth of the sleeping aids market is the rising number of insomnia cases. According to the Centers for Disease Control and Prevention (CDC), in 2016,  around 70 million adults suffered from insomnia in the U.S., with men reporting a higher rate of insomnia cases. Moreover, increasing geriatric population, changing life style with increase in consumption of alcohol, caffeine, and smoking, are some other factors leading to sleeping disorders. For instance, caffeine blocks the effectiveness of adenosine, a chemical that helps to bring on drowsiness and to regulate the sleep wake cycles.


On the basis of geography, the global sleeping aids market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America held the dominant position in the global sleeping aids market in 2016. This is attributed to rising number of sleep apnea disorders, which is a chronic disease that increases the risk of heart diseases, high blood pressure, depression, and diabetes. For instance, according to American Academy of Sleep Medicine, in 2014, around 25 million people were affected with sleep apnea disorder in the U.S.


Furthermore, Asia Pacific is expected to be the fastest growing region in the global sleeping aids market, owing to rising demand for sleeping pills due to stressful modern lifestyle. For instance, according to the Food and Drug Administration (FDA) in 2014, in Japan around 339 million sleeping pills were sold and the three most common drugs sold for the treatment of insomnia were Zolpidem (137.09 million pills), Estazolam (86.08 million pills) and Zopiclone (28.74 million pills)

 

 

Strategic partnerships among key players to deliver expert solutions for sleep apnea detection is expected to propel the market growth


Major players operating in the global sleeping aids market include Itamar Medical, SleepMed Inc, Teva Pharmaceutical Industries Ltd., Cadwell Laboratories Inc., and Drive Medical Ltd. Key players are focusing on strategic mergers and acquisition for development of novel products in order to provide better care for sleep disorders.


For instance, in August 2017, SleepMed Inc. announced its plans to enter into partnership with Early Sense, the inventor of Early Sense live, a sleep monitor that shares precise data with users about their sleep cycles. The objective of this partnership was to develop a sensor that can be used for monitoring disruptions throughout the night, including detection of interrupted breathing, heart rate, sleep cycles, and stress levels. The partnership will provide a comprehensive solution to its customers enabling better diagnosis and therapy.


About Coherent Market Insights:


Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.


Contact Us:


Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Like Reblog Comment
show activity (+)
review 2018-09-18 04:30
Rezension | Sag den Wölfen, ich bin zu Hause von Carol Rifka Brunt
Sag den Wölfen, ich bin zu Hause: Roman ... Sag den Wölfen, ich bin zu Hause: Roman - Carol Rifka Brunt,Frauke Brodd

Beschreibung

 

New York, 1987.

 

Die vierzehnjährige June Elbus ist ganz vernarrt in ihren Onkel Finn Weiss, der sich als gut gehandelter Maler etabliert hat, jedoch viel zu früh an einer Krankheit verstirbt die Junes Mutter kaum zu benennen vermag. Finn hinterlässt in Junes Leben ein großes Loch der Traurigkeit und sie hat das Gefühl mit ihrem Schmerz vollkommen alleine zu sein. Als June eine Nachricht des jungen Mannes Toby erhält, der behauptet Finn genau so sehr zu lieben, beschließt sie gegen den Willen und hinter dem Rücken ihrer Mutter eine Freundschaft zu Toby aufzubauen.

 

Meine Meinung

 

Schon alleine bei der Auswahl des Buchtitels „Sag den Wölfen, ich bin zu Hause“ hat Carol Rifka Brunt ein gutes Händchen besessen, denn er ist wunderbar poetisch, lässt gefährliches erahnen und steckt voller Verheißung auf eine bewegende und mitreißende Lektüre.

 

Worte für dieses Debüt zu finden, die alle Emotionen und Gedanken einfängt und nur ansatzweise meine Begeisterung abbilden, scheint mir fast unmöglich. Dennoch möchte ich mein Bestes geben und mich daran versuchen die spezielle Atmosphäre von Carol Rifka Brunt’s Geschichte zu umschreiben.

 

Vor allem der Facettenreichtum ist atemberaubend! Das etwas eigenbrötlerische Mädchen June wächst mit ihrer älteren Schwester Greta in einem behüteten Elternhaus heran. Mutter und Vater sind in der Buchmacherbranche tätig, so dass die Schwestern einen großen Teil des Jahres auf sich alleine gestellt sind – schließlich ist Steuersaison und da gilt es von morgens bis abends so einiges an Papierkram zu erledigen. Die Schwestern haben vielleicht gerade deshalb eine starke Bindung zueinander, doch diese ist seit einiger Zeit beschädigt und June kann sich nicht erklären warum ihre Schwester so abweisend und kalt zu ihr ist.

 

"Manches von dem, was Greta sagte, war so scharf, dass ich tatsächlich spürte, wie ihre Worte mich aufschlitzen, hinein in meinen Bauch und mein Herz." (Sag den Wölfen, ich bin zu Hause, Seite 298)

 

Die wohl wichtigste Bezugsperson in Junes Leben war ihr verständnisvoller und kluger Onkel Finn, der immer ein offenes Ohr für sie hatte und eine besondere Zeit mit ihr verbrachte. Gemeinsam besuchten sie Orte die für sie eine Bedeutung hatten (z. B. The Cloisters) und tranken Tee aus einer bemalten Kanne. Doch Finns Leben wurde durch eine Krankheit ein Ende gesetzt, die in den 80er Jahren zur Stigmatisierung führte (und auch heute noch dazu führen kann). Die Rede ist von AIDS. Junes Mutter fiel der Umgang mit dieser Krankheit äußert schwer und für all das Übel machte sie Finns „besonderen“ Freund Toby verantwortlich und selbst an Finns Beerdigung schneidet sie ihn.

 

June tritt dem Thema AIDS im Gegensatz zu ihrer Mutter viel aufgeschlossener entgegen und als Toby den Kontakt zu ihr sucht, ringt sie sich zu einem Treffen mit dem ihr fremden Mann, dem Finn so nahe stand, durch und lernt ihn langsam besser kennen. Es entwickelt sich eine besondere Freundschaft die June sehr viel gibt, aber schlussendlich auch sehr viel Schmerz verspricht.

 

"Das Leben schien ein immer enger werdender Tunnel zu sein. Im Augenblick der Geburt war der Tunnel riesengroß und unendlich lang. […] Dann, in exakt einer Sekunde nach der Geburt, verengte sich der Tunnel bereits um die Hälfte." (Sag den Wölfen, ich bin zu Hause, Seite 316)

 

Ein weiterer Strang des Gesamtkunstwerkes ist das Gemälde von June und ihrer Schwester Greta, welches Finn vor seinem Tod fertig stellte und das den Titel „Sag den Wölfen, ich bin zu Hause“ trägt. Von diesem Bild geht eine spezielle Faszination aus, die die Charaktere von Toby, June, Greta und Finns Schwester (die Mutter von June und Greta) miteinander wie durch ein durchsichtiges Netz verbindet.

 

Dieser Debütroman wird aus zahlreichen Puzzleteilen zusammen gesetzt, wie die Probleme des Erwachsen Werdens, des sich Selbst Findens, die Schwierigkeiten und Schönheiten des Geschwister Habens und dann wird auch noch die heikle Sache mit der Homosexualität und AIDS in den 80er Jahren eingewoben. Carol Rifka Brunt hat mich allerdings nicht nur mit der Geschichte von ihrer schriftstellerischen Qualität überzeugen können, sondern vor allem mit ihrem Schreibstil, bei der jede Seite wie ein frisch bezogenes Bett zum reinlegen und reinkuscheln verführt.

 

Fazit

 

Carol Rifka Brunt ist eine Wortkünstlerin und ihr Debütroman ein absolutes Lesehighlight.

Source: www.bellaswonderworld.de/rezensionen/rezension-sag-den-woelfen-ich-bin-zu-hause-von-carol-rifka-brunt
More posts
Your Dashboard view:
Need help?